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Objective: The study was designed to determine differences in blood loss and transfusion associated with a min-
imized cardiopulmonary bypass circuit versus a standard bypass circuit.
Methods: From February 2005 through April 2006, 199 patients were randomized to undergo coronary artery
bypass grafting with a standard cardiopulmonary bypass circuit (Medtronic, Inc., Minneapolis, Minn) or a min-
imized bypass circuit, the Medtronic Resting Heart Circuit. Laboratory perimeters (hemoglobin and platelet
count), were measured at baseline, after initiation of cardiopulmonary bypass, and on intensive care unit admis-
sion. Lowest values recorded were noted. Blood administration was controlled by study-specific protocol orders,
(transfusion for hemoglobin<8mg%). Patient demographic data were retrieved from the Society of Thoracic Sur-
geons database. Blood product administration was recorded during hospital admission, and chest tube drainage as
total output collected from operating room to discontinuation. Continuous variables were tested with a Wilcoxin
rank test, and categoric variables with X2 and Fisher’s exact tests.
Results: Hematocrit, equivalent at baseline, was higher in minimized circuit cohort at lowest point during cario-
pulmonary bypass (31.5% 3.9% vs. 25.5% 3.7%), after protamine (31.6% 3.9% vs 29.2% 3.7%), and on
intensive care unit arrival (35.2%  4.1% vs 31.8%  3.5%, P< .001). Similarly, platelet count was higher in
minimized circuit group on intensive care unit arrival, as was lowest platelet count recorded (170 3 103  48
cells/mm3 vs 1073 103  28 cells/mm3, P<.0001). Time to extubation was shorter in minimized circuit group
(848 737minutes vs. 526 282minutes, (P<.01), and total chest tube drainage was lower (1124 647mL vs.
506 214mL, P<.01). Fewer red blood cells (148 vs 19 units) were given inminimized circuit group (P<.0001).
Conclusions: A minimized cardiopulmonary bypass circuit provides less hemodilution, platelet consumption,
chest tube output and lower post-operative blood loss than standard cardiopulmonary bypass. Red blood cell
usage was also less. All differences are advantageous.C
S
PSince its introduction in the 1950s, cardiopulmonary bypass
(CPB) has allowed the development of heart surgery, which
has become the most common of surgical procedures per-
formed on a global basis.1 Even though CPB has been
used in millions of cases during the past 56 years, there
are still unsolved problems, many of which have been eluci-
dated in the past decade. These problems include but are not
limited to hemodilution, complement and white cell activa-
tion with systemic inflammatory response, platelet activa-
tion, the need for intensive anticoagulation, systemic organ
dysfunction, and the frequent need for blood and blood prod-
ucts to control postbypass bleeding or blood loss.2-5 Atrial
fibrillation (AF), the most common untoward event after
heart surgery, has also been related to CPB.6,7 To address
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doi:10.1016/j.jtcvs.2008.08.057The Journal of Thoracic and Csome of these concerns, surgeons initially began doing cor-
onary artery bypass grafting (CABG) procedures without the
use of CPB (off-pump CABG, or OPCAB).7,8 During the
1990s, OPCAB became popular; because of the technical
difficulties encountered in this procedure, however, as well
as a questionable effect on long-term graft patency, OPCAB
is currently performed in fewer of 25% of CABG proce-
dures.9,10 A further means of combating the side effects of
CPB has been the development of minimized circuits.6,11,12
These circuits minimize foreign surface–blood interaction
and are heparinized from tip to tip. The tubing length has
been shortened to decrease crystalloid prime. Importantly,
the use of cardiotomy suction is eliminated or minimized,
and an active air-removal device is added to this closed cir-
cuit. To evaluate the potential advantages of a minimized
circuit relative to a standard CPB (SCPB) unit, a prospective,
randomized trial was conducted.
MATERIALS AND METHODS
After investigation review board approval was received, 199 patients
older than 40 years who were to undergo first-time CABG were randomly
assigned to the use of a Medtronic Resting Heart (RHC) minimized circuit
(Medtronic, Inc, Minneapolis, Minn) or a standard Medtronic CPB circuit
(SCBP) at the time of surgical scheduling by means of computer-generated
randomization cards sealed in envelopes. The study was conducted from
February 2005 through April 2006. Exclusionary criteria includedardiovascular Surgery c Volume 137, Number 2 481




AF ¼ atrial fibrillation
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
MRH ¼ Medtronic Resting Heart minimized
circuit
OPCAB ¼ off-pump coronary artery bypass
grafting
RAP ¼ retrograde autologous priming
RHC ¼ Resting Heart circuit
SCPB ¼ standard cardiopulmonary bypass
coagulopathy (international normalized ratio>2), emergency surgery, and
surgery expected to last longer than 6 hours. Additionally excluded were pa-
tients who received 11b/111a platelet inhibitors, clopidogrel, or thrombo-
lytic therapy within 5 days of surgery; those who showed evidence of
ventricular or aortic aneurysm or ventricular thrombus; and those who re-
quired other concomitant therapy. Aprotinin was not used.
Operating personnel could not be blinded to circuit randomization. Ex-
tubation was carried out by intensive care unit (ICU) intensivist staff accord-
ing to the Beaumont Hospital protocol for all patients undergoing heart
surgery. The ICU physicians were aware that the patients were in the
CPB study, but did not know which circuit had been used. The study pa-
tients represented fewer than 20% of the heart operations conducted during
the study period.
Transfusion of red blood cells was controlled intraoperatively and post-
operative by a study-specific protocol to administer blood if hemoglobin fell
below 8 mg/dL in both groups. There were no protocol violations.
Intraoperative fluids were limited by protocol, and perfusion pressure
was maintained during retrograde autologous priming (RAP) by pressor ad-
ministration. RAP was discontinued if patient hypotension related to hypo-
volemia occurred.
Hematologic Parameters and Other Data
Laboratory parameters recorded included hematocrit on entry to the op-
erating room, after the administration of heparin, at its nadir during CPB,
after protamine administration and, on arrival at the ICU. Platelet count
was measured at baseline, on admission to the ICU, and as the lowest plate-
let count recorded during the hospital stay.
During the hospital stay, the total numbers of units of blood andbloodprod-
ucts were recorded, and the timing of product administrationwas noted. Chest
tube drainage was recorded as total output collected from the operating room
drainage initiation to chest tube discontinuation, and extubation timewasmea-
sured from arrival at the ICU until the endotracheal tube was removed.
Pertinent demographic data, operative data, and postoperative adverse events
were retrieved from the Society of Thoracic Surgeons database collection.
Circuit Description
The RHC was selected for use after a large experience with routine heart
surgery. A closed circuit (containing an active air-removal device) with
a centrifugal pump and Carmeda-coated (Carmeda AB, Upplands Va¨sby,
Sweden) high-efficiency oxygenator forms the core of the system (Figure 1).
The tubing consists of a 48 3 0.375-inch arterial line and 84 3 0.375-inch
venous tubing, as opposed to the SCPB circuit, with tubings 803 0.375 in-
ches and 120 3 0.5 inches, respectively, thus minimizing crystalloid prim-
ing volume to approximately 900 mL versus 1850 mL. Because of the
shorter tubing length, the circuit has to ‘‘nestle’’ closely to the patient, mak-
ing the vertical array an important space-saving feature. The RHC is coated482 The Journal of Thoracic and Cardiovascular Surtip to tip with a Carmeda heparin surface. Our circuit included a Trillium-
coated (BioInteractions Ltd, Reading, UK) reservoir limited to aortic root
vent return, thus rendering the circuit semiclosed.13
Heparin was administered (350 units/kg) to maintain activated clotting
time greater than 400 seconds. Standard aortic and venous cannulations
were undertaken, and in the RHC group kinetic assistance was used for ve-
nous drainage (40–50 mmHg suction). After cannulation, RAP was used to
displace all but 300 mL of crystalloid prime in the RHC to a bag reservoir,
which was separated from the circuit and reinfused to the circuit after CPB,
displacing blood from the tubing. All salvaged cells were washed and rein-
fused. In contrast, the Medtronic SCPB circuit, as noted, used the same bio-
pump and oxygenator but did not have an active air-removal system. The
SCBP membrane oxygenator and reservoir were Trillium coated. RAP
was also used in the SCBP cohort; because of patient hypotension, however,
only about half of the 1850-mL volume could be displaced.
Patient Population
There were 199 patients randomly allocated, 97 to SCPB and 102 to
RHC.Mean age was 67 10 years (range 39–86 years). Demographic char-
acteristics of the patients are shown in Table 1, and the operative procedures
are shown in Table 2. The left internal thoracic artery was used in all cases.
Proximal and distal anastomoses were conducted under aortic crossclamp
with the heart stilled by the administration of surgeon-specific cardioplegic
solution. There was no 30-day mortality. One SCBP patient was returned to
the operating room for surgical bleeding. One patient in each group required
intraoperative balloon placement.
Statistical Analysis
Continuous variables were tested with a Wilcoxon rank test, a nonpara-
metric approximation of the t test. Categoric variables were examined with
a c2 test; otherwise, a Fisher exact test was used. Values are expressed as
mean  SD.
FIGURE 1. Medtronic Resting Heart circuit (Medtronic, Inc, Minneapolis,
Minn) used in trial.gery c February 2009




CPB times were similar between groups (76 20 minutes
for SCBP and 75 20 minutes for RHC, P>.05). As shown
in Table 3, the hematocrit was significantly higher at all
times after the initiation of CPB with the RHC as opposed
to the conventional circuit. Similarly, platelet count was
higher in patients in whom the RHC was used at all times
after baseline. The times to extubation were 848 737 min-
utes in the SCBP group and 526  282 minutes in the
RHC group (P < .01). Total chest tube drainage in the
SCPB group (1124  647 mL) was greater than that in
the RHC group (560  214 mL (P< .001). In addition to
the blood count being higher in patients in the RHC group,
more patients in the SCBP group required the use of red
blood cells, and a greater number of red cell units were given
both on bypass and during the hospital stay in the SCBP
group (Table 4). The use of platelets in the operating room
(8 vs 3 patients) and in the ICU (4 vs 3 patients) was not sta-
tistically different (P>.5) for SCBP versus RHC. Similarly,
the use of fresh-frozen plasma was minimal, with a total of 5
units versus 1 unit for SCBP and RHC groups, respectively.
Cell salvage reinfusion was not different between the RHC
and SCBP groups (716  256 mL and 810  346 mL,
P>.05). Postoperative AF occurred in 16% of the patients,
14% in the RHC group and 19% in the SCBP group, with
the difference not reaching significance. Cerebrovascular
accidents were equally distributed, with 2 events in each
group, and were all minor, requiring no therapy. There
were no postoperative sternal wound complications.
TABLE 1. Demographic characteristics by circuit type
Standard Minimized Total
Sex
Male 68 (70%) 74 (73%) 142 (71%)
Female 29 (30%) 28 (27%) 57 (29%)
Age (y)
Mean  SD 66.7  10 67.4  10
Range 44–84 39–86
Height (cm)
Mean  SD 172  8 173  9
Range 152–188 150–193
Weight (kg)
Mean  SD 84  16 85  16
Range 50–122 53–116
Body surface area (m2)
Mean  SD 1.96  0.2 1.99  0.2
Range 1.53–2.5 1.50–2.4
P not significant for all comparisons.The Journal of Thoracic and CDISCUSSION
Several models of minimized CPB circuits have been de-
veloped and used on a global basis, although as yet for a mi-
nority of patients.11,12,14-17 Remadi13 has noted excellent
exposure for complete revascularization and, in more than
1500 cases, found neither systemic injury nor occult air em-
bolism, consistent with other reports.18-21 A minimized cir-
cuit has been used in all forms of heart surgery, including
CABG, aortic valve replacement, and robotically enabled
mitral valve surgery.17,22,23 This randomized trial confirms
previous non-American studies indicating that less blood
administration is needed after minimized circuit use, with
less blood loss during the immediate postoperative pe-
riod.4,12,19,20 This is of particular importance because the ad-
ministration of red blood cells can increase postoperative
morbidity and mortality.24,25 Even after a successful surgical
outcome, red blood cell transfusion has also been shown to
reduce long-term survival.26 Thus it is important to eliminate
transfusion.
The salutary effect of the minimized circuit is likely due to
several factors. First, hemodilution is minimized by the
shortened tubing length and the smaller inner diameter of
tubing used, thus not only maintaining a higher hematocrit
during the operative procedure and after CPB but minimiz-
ing the dilution of coagulation factors. Along with minimiz-
ing the blood–foreign surface interface, the shortened tubing
with its tip-to-tip heparin coating also minimizes platelet ac-
tivation. Because of the previously mentioned factor, less in-
tensive anticoagulation is necessary during the CPB run,
enabling better postoperative hemostasis.27 In our experi-
ence, approximately two thirds of the traditional hepariniz-
ing dose for the SCPB circuit is used.17 RAP is also an




(n ¼ 102) P value
Hematocrit (%)
Baseline 36.6%  5.0% 35.7%  5.0% .25
After heparin 35.3%  5.0% 34.2%  4.8% .09
Lowest during CPB 25.5%  3.7% 30.5%  3.9% <.0001
After protamine 29.2%  3.7% 31.6%  3.9% <.0001
SICU 31.8%  3.5% 35.2%  4.1% <.0001
Platelets (103 cells/mL)
Baseline 218  55 228  68 .49
SICU 117.4  31.1 186.4  51.2 <.0001
Lowest count 106.9  28.5 169.2  47.5 <.0001
Data are mean  SD. CPB, Cardiopulmonary bypass; SICU, surgical intensive care
unit.TABLE 2. Number of grafts per procedure by circuit type
Circuit CABGx1/Lima CABGx2/Lima CABGx3/Lima CABGx4/Lima CABGx5/Lima Totals Per Pt
Conventional 1 4 57 27 8 97 3.38
MRHS 0 7 45 38 11 101 3.52
Totals 1 11 102 65 19 199 P ¼ 0.16ardiovascular Surgery c Volume 137, Number 2 483
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Pimportant factor in red blood cell conservation and minimi-
zation of hemodilution; however, RAP was used in all cases
in both groups, yet hemoglobin was higher and red blood
cell use lower with the RHC at all times after the initiation
of CPB. Thus RAP alone cannot explain all the salutary ef-
fects of the minimized circuit. Finally, because of the mini-
mized closed circuit, the heparin coating, and, importantly,
the decreased air–blood interface, the activation of white
blood cells releasing inflammatory factors is minimized.
Earlier extubation is likely related to less hemodilution and
white blood cell activation, consequently resulting in less
third-space edema.18
Immer and colleagues6 found improved myocardial pro-
tection in patients undergoing surgery with the minimized
circuit as opposed to SCBP. In addition to improved protec-
tion, patients with theminimized circuit had less weight gain,
and the authors believed these facts to be primarily responsi-
ble for the lower incidence of postoperative new-onset AF in
their minimized circuit patients. Koch and coworkers28
found red blood cell transfusion to be associated with an in-
creased risk of AF. We found no difference between groups
in the incidence of AF. In patients at higher risk for AF, how-
ever, the impact of a minimized circuit may be more notice-
able. Other reports have indicated that the minimized circuit
offers similar decreases in all the previously mentioned pa-
rameters, which is more similar to OPCAB surgery than to
SCBP; however, the use of RHC facilitates complete revas-
cularization, especially for complex anatomy or unstable
physiology not amenable to OPCAB.13,14,16
The systemic inflammatory response is the result of the
activation of both cellular and humoral components.
Although this study did not undertake the measurement
of inflammatory markers, others have noted a decrease in
the inflammatory response with minimized bypass cir-
cuits.4,14,15,18,29 Inflammatory response activation may con-
tribute to myocardial dysfunction, respiratory failure, renal
insufficiency, confusion or stroke, and AF.3,4 Eliminating
or minimizing these effects is desirable.
A learning curve is necessary but is not associated with
higher risk.13,19 There are three drawbacks to the minimized
circuit that become apparent during its use. First, communi-
cation between the perfusion, anesthesiology, and surgical
teams is more imperative than with SCBP. The blood pres-
sure has to be maintained during RAP, and active communi-
cation when CPB is initiated is necessary to determine
adequacy of perfusion because the circuit has been primed
with the patient’s blood.




(n ¼ 102) P value
Transfusion at any time (No.) 49 (51%) 16 (16%) <.0001
Total packed red blood cells (units) 148 19 <.0001
Transfusion during bypass (No.) 38 (39.2%) 7 (6.9%) <.0001484 The Journal of Thoracic and Cardiovascular SurSecond, the effect of the minimal circuit volume and ret-
rograde autologous priming may be obviated if too much
crystalloid volume infusion is administered before and dur-
ing the case. In this study, fluid was controlled by protocol,
and perfusion pressure was maintained during RAP by pres-
sor agent infusion.
Finally, because kinetic assistance is necessary, emptying
of the heart with decreased perfusion flow can at times be
difficult. One needs to ensure a complete seal around and
proper positioning of the venous drainage cannulas to prevent
air entering the circuit. and the surgeon must maintain active
observation on the heart should the right atrium or right
ventricle dilate with undrained volume, communicating with
the perfusionist to improve drainage.19 There are specific
instances—including the administration of cardioplegic solu-
tion, discontinuation of vent drainage, and, importantly, car-
diac manipulation, particularly pulling the heart superiorly
and to the right for access to the circumflex coronary artery
system–that can impede venous drainage and lower perfusion
flows. Drainage issues can also occur with vigorous traction
on the left atrium during mitral valve surgery. Active commu-
nication among all portions of the surgical team is mandatory.
Air entry to the RHC was not encountered. The active air-
removal system cleared any air that might enter the venous
cannula and obviated, even eliminated, the occult air embo-
lization that has been seen with SCBP.19
In summary, the RHC offers a viable alternative to the
SCPB circuit. It has been associated with less postoperative
blood loss, lower transfusion rates, and earlier extubation,
while allowing adequate exposure for cardiac surgical pro-
cedures. This was a series of low-risk CABG surgical pa-
tients, and those in populations at higher risk may achieve
greater benefit.
We acknowledge the work of Nicholas A. Tepe, MD, Phillip L.
Robinson, MD, Joseph S. Bassett, MD, Goya V. Raikar, MD,Mark
Pica, RN, and Joan Benedetti, RN, without whose efforts the pro-
ject would be incomplete.
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